1. Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia. (29th July 2015) Authors: Assouline, Sarit; Buccheri, Valeria; Delmer, Alain; Gaidano, Gianluca; McIntyre, Christine; Brewster, Michael; Catalani, Olivier; Hourcade‐Potelleret, Florence; Sayyed, Pakeeza; Badoux, Xavier Journal: British journal of clinical pharmacology Issue: Volume 80:Number 5(2015:Nov.) Page Start: 1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial. Issue 3 (March 2016) Authors: Assouline, Sarit; Buccheri, Valeria; Delmer, Alain; Gaidano, Gianluca; Trneny, Marek; Berthillon, Natalia; Brewster, Michael; Catalani, Olivier; Li, Sai; McIntyre, Christine; Sayyed, Pakeeza; Badoux, Xavier Journal: Lancet Issue: Volume 3:Issue 3(2016) Page Start: e128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗